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Roll Back Malaria Initiative encourages participation of private health providers in malaria control because mothers seek care for
sick children from them. This study investigated Patent Medicine Sellers (PMS) management of presumptive malaria in children
in order to identify how they can assist malaria control. A cross-sectional survey of 491 PMS in Kaduna, Nigeria, was done using
interviews and observation of shop activities. Most (80%) customers bought drugs without prescriptions. Only 29.5% were given
instructions about doses. Between 40–100% doses of recommended antimalarials were incorrect. Some (22%) PMS did not ask
questions about illness for which they were consulted. Most children treated in shops received injections. PMS facilitate homecare
but have deﬁciencies in knowledge and practice. Interventions must focus on training them to accurately determine doses, give
adviceaboutdrugadministration,useoralmedication,andaskaboutillness.Trainingshouldbemadeaprerequisiteforregistering
and reregistering shops.
1.Introduction
If Africa is to achieve the Millennium Development Goal
(MDG) of reducing childhood mortality by two thirds
by 2015, new approaches to healthcare delivery must be
developed [1]. Despite various national and international
eﬀorts, malaria still remains a major cause of childhood
mortality accounting for about 800,000 deaths annually [2,
3]. As over 80% of these deaths occur in African children
under the age of ﬁve, it will be diﬃcult to achieve the
MDG goals without substantially reducing the burden of
malaria [3]. The Roll Back Malaria (RBM) Partnership
was established to coordinate a global approach to combat
malaria, and at an RBM meeting in 2000, African heads of
the state pledged to ensure that 60% of people suﬀering from
malaria have access to aﬀordable and appropriate treatment
within 24 hours of the onset of illness and 60% of children
and pregnant women sleep under Insecticide-treated Nets
[3]. Treatment starting within 24 hours of the onset of
symptoms prevents progression to severe malaria or death
[4]. However strategies to achieve this goal must take into
account populations that do not patronize public health
facilities or are inadequately served by them. Often children
do not reach public facilities untill three or more days after
the onset of symptoms because they are treated at home
or by private health providers in the community [5–9]. Yet
until recently private health providers were not the focus
of intervention programs but now the Roll Back Malaria
Initiative is encouraging participation of all private Health
Providers within overall government strategies for malaria
control [9].
Patent medicine sellers (PMS) are a large group of
informal private health providers found in many countries
who operate as shop keepers, traders in periodic markets,
itinerant drug peddlers, and wholesale drug merchants [10,
11]. Those who operate from shops are patronized by people
from all segments of the community especially the poor
because they are perceived to be more accessible, caring, and
aﬀordable than public health facilities [7, 8, 10–12]. They
are a source of drugs, advice, and treatment for illnesses in2 Malaria Research and Treatment
many communities [10–16]. They have no formal pharmacy
training but are licensed to sell proprietary and over-the-
counter drugs [16]. However many of their practices have
been reported to be substandard [10, 14, 15]. Policy makers
havegenerallyignoredthem,attemptedtoredirectcustomers
away from them, or tried (usually unsuccessfully) to enforce
regulations preventing them from acting as health providers
[10, 17]. Few reported interventions have tried to work with
them to improve management of malaria, and there is little
or no exchange of information or collaboration between
government bodies and PMS. The result is that there is a
huge,largelyunregulatedresourcewhichisnotbeingutilized
to contribute to national child survival initiatives [10, 17].
But because 15%–82% of caregivers in sub-Saharan Africa
ﬁrst consult them for treatment of their sick children, it is
increasingly being recognized that they must be included in
malaria control programmes [10, 17].
Various strategies like information, incentives, persua-
sion, social marketing, franchise, or accreditation have been
suggested to improve their practices [10, 17, 18]. These
all need research into which method or combination of
methods is the best, but whichever method is used, PMS
would need to acquire some basic knowledge and probably
training. In order to determine how best PMS can be used
in malaria control in children, it is important to determine
exactly what they do for sick children. Such information
however has been based mainly on interviews, use of mystery
clients and anecdotes [19–22]. Few studies have documented
what actually happens when caregivers visit PMS shops [23].
Partly because of the attitude of some health professionals
and partly for fear of legal repercussions, PMS are often
reluctant to divulge information about their activities. Even
where they do, there is sometimes a discrepancy between
what they say they do and what they actually do [22].
Ideally, studies about PMS should involve a combination of
methods, for example, direct observations of their activities
and interviews to allow for validation and increase of the
relevance and generalization of results [24]. For this reason
a combination of methods was used in this study whose aim
was to investigate how PMS manage presumptive malaria
in children under 5 years in Kaduna, Nigeria, speciﬁcally
to determine the characteristics of PMS and the services
they oﬀer, and for those who manage children, to document
how they identify and treat presumptive malaria. It is hoped
that the ﬁndings would provide program managers and
policy makers substantial grounds to integrate PMS into
malaria control programs and assist in the development of
interventions for them. This would help reduce childhood
mortality in Nigeria and other countries where PMS operate.
2.SubjectsandMethods
2.1. Background of Study Area. Nigeria, the most populous
country in Africa, has one of the highest childhood mortality
rates in the world with malaria accounting for 30% of
mortality [25, 26]. Kaduna city is the capital of Kaduna State.
It was the capital of the former Northern region and is an
important city in the North of Nigeria. It is situated in the
Northwestern health zone which has the highest Under-Five
Mortality Rate of the six health zones in the country [27]. In
the early 1900s, various parts of the country were linked to
Kaduna by rail. This led to people of diﬀerent ethnic groups
migrating to Kaduna. People from the major ethnic groups
(Hausa, Yoruba, and Ibo) and numerous minor ethnic
groups have settled in Kaduna. The main local language
spoken by most residents is Hausa, but a lot of people are
multilingual. The residents of Kaduna practice Christianity,
Islam, and traditional religions. Sometimes ethnic and
religious tensions erupt into riots (the last occurred in
2000). Many people work in the textile, car assembly, and
oil reﬁning industries, the civil service, and the small-scale
businesses[28].Thecityismadeupof2administrativeareas:
Kaduna North and South Local Government Areas (LGAs).
Each LGA is a mixture of high-, medium-, and low-density
areassupportingvariouscommercialandindustrialactivities
with people of diﬀerent sociocultural, ethnic, and religious
backgrounds. The city had an estimated population of a
million at the time of the study.
Knowledge about PMS management of sick children in
Kaduna is scanty as most studies about PMS were carried
out in Southern Nigeria where the population, culture, and
perceptions diﬀer from those of the North. Studies from
the South were carried out in urban and rural areas but
involved populations which were homogenous in ethnicity
and religion [7, 20, 29]. In contrast, Kaduna is an urban
area with a heterogeneous population in terms of religion,
ethnicity and culture [28]. Though there are no published
data, it appears that the proportion of people patronizing
PMS in Kaduna is increasing in spite of the presence
of many orthodox health facilities including a University
Teaching Hospital, a paediatric hospital, 3 general hospitals,
10 primary healthcare centres, and 93 registered fee-paying
private hospitals.
PMS are expected to be over 21 years of age with at
least primary school education before they can be registered
by the State Ministry of Health (SMOH) [16]. Registered
PMS are issued licenses which they are supposed to renew
every year and display in their shops. The Task Force of
the SMOH carries out periodic inspections to make sure
that PMS comply with regulations. Kaduna city had 220
registered PMS shops. There are also an unknown number
of PMS who, because they are not registered by the SMOH,
are not supposed to sell drugs but who nevertheless do
so. Both registered and unregistered PMS belong to the
National Association of Patent and Proprietary Medicine
Dealers (NAPPMED), membership of which is voluntary.
2.2. Study Design. The study carried out in 2003 was a
cross-sectional, descriptive survey of all PMS in Kaduna
South LGA. Only PMS operating in shops (registered and
unregistered) were studied because these appear to be the
ones most patronized by caregivers of sick children [10, 11,
17]. Traders in periodic markets, itinerant drug peddlers,
and wholesale drug merchants were excluded. PMS shops
were identiﬁed by research assistants who combed the area.
Two research instruments were used—a questionnaire used
to interview PMS and a detailed checklist used during direct
observation of customer-PMS interactions. A pretest wasMalaria Research and Treatment 3
carried out in an area similar to but far away from the study
area to validate both instruments.
The questionnaire was translated from English to Hausa
(the commonest local language in the study area) and
backtranslated into English by an independent translator
to ensure correct translation. The translation was done so
that it could be used for PMS who were not ﬂuent in
English. The questionnaire contained questions about the
characteristics of PMS, the shop, the services they oﬀered
both adults and children, and the methods they used to
identify and manage or refer children with presumptive
malaria. An inventory of drugs sold for malaria in the week
preceding theinterview wastaken.Questions werealsoasked
about the type, the methods of administration, and the doses
of medicines (if any) given to treat children they thought
had malaria. The questionnaire was administered by trained
research assistants, and interviews were carried out with the
PMS who attended to customers.
The detailed checklist was used to record the number,
sex, estimated ages, and actions of all visits by customers
whether these visits were of a medical nature; it also recorded
the response of PMS (including whether the customer was
asked questions about illness, sale of drugs, giving of advice,
physical examination, and any treatment given). During the
visits, trained research assistants recorded activities in shops
and observations were made of customer-PMS interactions.
Thiswasdoneatdiﬀerenttimesofthedayforonehourusing
the detailed checklist. A maximum of 20 observations per
shop were recorded in the one-hour period. Data recorded
were based on consecutive arrival of clients at shops. In order
to minimize interference with customer-PMS interactions,
the research assistants did not interfere with shop activities
or ask customers any questions and no exit interviews of
customers were done.
2.3. Sample Size Estimation. Studies which conducted obser-
vations of customer-health worker interactions at govern-
ment health facilities recorded diﬀerent numbers of observa-
tionsrangingfromtwoobservationspercondition[30]tosix
observations per facility [31]. None of these studies provided
a rationale for the number of observations made or the
timespent.ShopobservationsstudiesfromSouthernNigeria
indicated that 10 observations per shop were adequate to
obtain signiﬁcant information and avoid the cluster eﬀect of
thesameindividualrepeatinghisbehaviour[23].Furtherthe
studypretestindicatedthatapproximately50%ofcustomers’
visits were for nonmedical purposes and about 20% of sales
concern children less than 5 years.
Kaduna city had 220 registered PMS shops. Thus the
number of total observations needed for the shops was
calculated as 220 × 10 = 2200. INSTAT V2.02 (Graphpad
software1990–1993) was used to calculate the sample size.
A 5% level of precision was used taking into account the
resources available for the study.
At expected sales for children of 20% (±5%), with α =
0.05 and β = 0.20, the minimum number of visits by
customers that would give an adequate number of customer-
PMS observations was calculated to be 471. The visits that
represent under-5 children equal 2200 ÷ 471 = 4.6 ∼ = 5.
Thus the number of visits that will represent total children
visits equals 5×220 = 1100. With an estimated 10 customer-
PMS observations per shop, the total number of shops to
be studied equals 1100 ÷ 10 = 110. Since this represented
the approximate number of shops in one LGA of the city, all
the PMS in the LGA were to be surveyed. As approximately
50% of customers’ visits were for non-medical purposes, the
number of observations was increased to 20. This was the
maximum number of customer-PMS observations recorded
in the one-hour period the by the trained researcher.
2.4. Ethical Approval, Consent, and Conﬁdentiality. Approval
was obtained from the Scientiﬁc and Ethical Committee of
Ahmadu Bello University Teaching Hospital, Zaria, Nigeria
and the Institutional Review Board of Boston University,
North America. Informed consent was obtained from the
State Chairman of the National Association of Patent and
Propriety Medicine Dealers (NAPPMED), each local head of
NAPPMED,theownerofeachshop,andindividualsenrolled
in the survey. Conﬁdentiality was ensured and no person or
shop was identiﬁed by name.
2.5. Data Management. Variables analyzed included charac-
teristicsofthePMS,theshop,customers,andchildforwhom
help was sought. Drugs PMS recommended for malaria
were classiﬁed into pharmacological groups and doses were
classiﬁed as correct, underdose, or overdose in accordance
withnationaltreatmentguidelines,forexample,chloroquine
dose was deemed appropriate when given orally in a dose
of 25mg/kg base over 3 days [32]. Possible factors that
could inﬂuence the behaviour of diﬀerent groups of PMS
(e.g., gender, age, educational background, and location of
shop) were compared in terms of proportions and tests of
signiﬁcance using chi-squared tested and Student t-test to
detect statistically signiﬁcant diﬀerences (P<. 05). Statistical
analysis was done with EPIINFO version 6.04. PMS with
missing information were excluded when calculating signiﬁ-
cance levels.
3. Results
3.1. Characteristics of Shops. All PMS shops in the Kaduna
South LGA were to be included in the study. The expected
number of shops was 110, but on the ﬁeld, a total of
544 shops were identiﬁed. However 53 (9.7%) owners were
unavailable or refused to participate in the study mainly
because of suspicion that researchers were members of the
State Monitoring Task Force. Most 440 (89.6%) of the
remaining 491 shops claimed to be registered but only
56% displayed licenses. The majority (87.8%) of shops was
situatednearbusyplaces(main roadsor markets),8.1%near
health facilities, and the rest near hotels, places of worship,
or residential areas. Most of them (94.7%) were open 6 or
7 days a week from early morning untill late at night, and
48.3% also sold general store items. Services available for
children less than 5 included giving medical advice (97.8%),
consultation for illness (94.7%), administration of injections
(40.7%), and intravenous ﬂuids (18.5%). Some shops (37%)4 Malaria Research and Treatment
Table 1: Characteristics of patent medicine sellers.
Sex Number (%)
Male 328 (66.8%)
Female 163 (33.2%)
Age (years)
<21 34 (6.9%)
21–40 374 (76.2%)
>41 73 (14.9%)
Highest education attained
Primary 44 (8.96%)
Secondary 255 (51.9%)
Tertiary 192 (39.1%)
Training in orthodox healthcare
None 374 (76.2%)
Healthcare training 117 (23.8%)
Dentists 2
Nurses/Midwives 97
Other 18
had the services of a medical doctor or nurse (mostly on a
part-time basis) to see patients.
3.2. Characteristics of PMS (Table 1). PMS consisted of 370
owners (75%), 63 apprentices (13.8%), and 58 employees
o rr e l a t i v e s( 1 1 . 8 % ) .T h e i ra g e sr a n g e df r o m1 5t o8 0y e a r s
and all were literate. While some, 117 (23.8%), had received
training in healthcare, most had not. 104 PMS (21.2%) had
other jobs, with 63 (14.7%) working in hospitals.
3.3. Report of Observations of Visits by Customers to PMS
Shops. Most 1584 (61.9%) of 2557 visits were made for
medical reasons (the others were for purchase of non-
medical items or social visits). Of these medical visits,
1266(79.9%) were of customers who came to request for
drugs without prescription and 117 of these requests were
obviously for children. Just 19 (1.2%) customers presented
prescriptions for drugs for children. In most instances PMS
simply sold the drugs requested. Only 29.5% gave customers
instructions about doses, 2.6% about side eﬀects, and 0.8%
about precautions. Of 291 people who complained about
illness, 86 (29.6%) complained about children’s illnesses, but
49 (57%) did not bring them. Three customers were asked to
go back and bring the children but 19 PMS sold caregivers
drugs without asking any questions about the illness. Of 37
(43%)childrenbroughtfortreatment,5wereaskedtoreturn
later and 3 were sent into an inner room where the observer
could not determine what happened. PMS were observed
treating 29 children for fever, diarrhea, injuries, and skin
lesions. Twenty-seven (93%) PMS asked for clariﬁcation, 21
(75%) examined the children, 7 (18.9%) dressed or stitched
wounds, and one gave a child an intravenous infusion. Most
27 (93%) children received injections. Caregivers of children
treated in shops were given advice about doses of drugs. Two
children (with severe measles and sickle cell disease) were
referred.
Thus at least 222 visits (117 drug requests, 19 prescrip-
tions, and 86 consultations) involved children representing
14% of shop visits.
3.4.ManagementofPresumptiveMalaria:ReportofInterviews
(Figure 1, Table 2). PMS were speciﬁcally asked about how
they identiﬁed and managed children they thought had
malaria.
3.4.1. Identiﬁcation of Malaria. Only 18 (3.7%) of the 491
PMS studied stated that they did not treat children for
malaria because they did not see children or they referred
them. The remaining 473 PMS used various combinations
of methods to identify malaria. 226 (47.8%) used past expe-
rience, 189 (39.6%), physical examination, and 21(4.4%)
used laboratory tests. The main symptoms used to identify
malaria were fever 318 (66.1%), inability to eat 98 (20.7%),
weakness 70 (14.2%), eye discoloration 29 (6.1%) and
vomiting 29 (6.1%). Only one PMS mentioned convulsions.
3.4.2. Drug Therapy. There was no diﬀerence between types
a n dd o s e so fd r u g su s e db yP M Sw h oh a dr e c e i v e dp r o -
fessional health training and those who had not (P>. 5).
PMS stated they used antimalarials, antipyretics, vitamins,
antibiotics,andantitussives.429PMSwhogaveantimalarials
(90.7%) used chloroquine, 36 (7.6%) used Sulfadoxine-
pyrimethamine (at the client’s request), 6 (1.3%) used
Halofantrine, and 2 (0.4%) used quinine. However 40%–
100% of stated doses of the diﬀerent antimalarials; were
incorrect. No PMS mentioned Artemisinin based-products.
3.4.3. Nondrug Therapies. Only 116 (19.4%) PMS recom-
mended that caregivers should use methods to reduce the
child’s temperature (exposure, tepid sponging, and cold
baths). 23 PMS (4.9%) recommended practices (hot baths,
covering the child) which could lead to increase in tempera-
ture. Just 60 (12.7%) PMS mentioned use of mosquito nets
(mainly more often by PMS who were health professionals;
P = .03).
3.4.4. Referral. Forty (57%) of 70 PMS who had recently
referred children had treated them for three or more days.
Reasons for referral were inability to handle the illness, 27
(38.6%), lack of improvement, 25(35.7%), severe illness, 6
(8.6%),orlaboratorytests,2(2.9%).Therestgavenoreason.
3.5. Drug Inventory. In the week preceding the survey, PMS
estimated that they had sold 8,430 doses of paracetamol,
5,413 doses of chloroquine (mainly syrups, also tablets,
and injections), 102 doses of sulfadoxine-pyrimethamine,
and 3 doses of quinine. Chloroquine and paracetamol
were popular because they were eﬀective, well known to
customers, and cheap (less than two US dollars).
4. Discussion
Improving access to prompt, eﬀective, and appropriate
treatment is a key element of the Global Malaria ProgrammeMalaria Research and Treatment 5
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Figure 1: Drugs used by Patent Medicine Sellers in treatment of
Malaria.
Strategy [2, 3]. The study shows that PMS have the potential
to improve access, but they need skills and knowledge to
manage malaria. They acted mainly as facilitators for home
care (as the great number of requests by their customers
for drugs without prescription indicates a community that
was actively involved in self-care). PMS also treated sick
children brought to the shop. However they had deﬁciencies
in knowledge and practice. Many did not know the correct
dose of antimalarials children should receive. Most failed to
give customers advice about drug doses or administration.
Some did not ask questions about illness for which they were
consulted, and many used injections to treat children. Few
promoted non-drug methods of treatment or use of bednets.
Other studies reveal that PMS frequently give no or
inappropriate advice about drugs [10, 14, 15, 17]. This
highlights one weakness of Home Management of Malaria
(HMM) which aims to ensure prompt and eﬀective care
of sick children by educating mothers and distributors of
antimalarials in the community [33, 34]. Many mothers in
developing countries get drugs from PMS or drug hawkers—
usually without prescription [10, 17, 19]. Unfortunately,
because the person selling the drug or the one administering
it does not know the correct dose, children are given
inappropriate doses of antimalarials leading to development
of severe disease and death [10, 17, 35, 36]. The study
shows that interventions involving PMS should focus on
training them to determine the correct dose of antimalarials
and encourage them to give customers advice about admin-
istration. Children’s doses vary and are usually calculated
using weight, surface area, or age. As most children were
not taken to the shops, use of weight or surface area is
clearlyimpracticalbutusingageisfeasible.Insomecountries
antimalarials are prepackaged or colour coded according to
age, and these have been used with great success [37, 38].
In many areas, though, such drugs are not available or
aﬀordable, and so other simple methods of determining
doses are needed. Age could be used to calculate dose as a
percentage of the normal adult dose but PMS would need
training on how to do this. Pictorial guides in the shop and
inserts in drugs packets could help but inserts increase cost
of drugs.
PMS also need to know about changes in malaria
treatment. It is striking that none of them mentioned
Artemisinin-Combination Therapies (ACTs). This might
have been because, at the time of the study, ﬁrst-line
treatment consisted of chloroquine which was cheap and
eﬀective. Due to increasing drug resistance, the government
changed its malaria treatment policy and adopted ACTs as
ﬁrst-line drugs in 2005, but many PMS were unaware of
this [39, 40]. At present, though, ACTs cannot legally be
sold by PMS because they are classiﬁed as prescription drugs
[39]. Changing their status to over-the-counter requires
legislation,aprocessthatiscurrentlyunderwayastheFederal
Ministry of Health proposes to use ACT at community level
to improve HMM [39]. Use of ACTs might also help reduce
the high rate of injections given to children treated in shops
and so reduce risk of infection, nerve paralysis, and danger
to the community caused by improper disposal of needles.
It is of note that some PMS dispensed drugs without
asking questions (in essence relying on the caregivers’
diagnosis). The importance of PMS asking questions about
illness, for which they are consulted needs to be stressed
because it helps identify those children who need urgent
referral to health facilities For example, those with danger
signs like vomiting, refusal, or inability to feed [41].
The study was limited in that some PMS were cautious
about letting researchers see how they treated children
because the Government Task Force was threatening to close
down shops for illegal activities. Thus it is likely that many
more children were treated than was recorded. Also some
PMS may have adopted diﬀerent behaviours to their normal
onesbecausetheywerebeingobservedbutthemostprobable
result of this would be that more,not less, PMS than normal
would give customers advice about drugs. Determining the
eﬀect medical personnel who were not PMS had on patient
management was outside the scope of the study, so was
determining the accuracy of PMS diagnosis of illnesses, the
doses they actually gave, or the extent their advice or lack of
it had on the health of their customers.
The study shows that PMS need training in order to
improve their role in malaria control in the community.
However generally governments of developing countries
have been reluctant to train informal health providers and
instead have concentrated on training health workers in the
public sector [10, 17]. Both knowledge and practices can
be improved through training. In Nigeria, training PMS
on a range of common conditions in adults led to an
improvement in their knowledge though the impact on their
practicewasnotevaluated[23].InKenya,trainingresultedin
an increase in the proportion of antimalarial drug users who
receivedanadequatedose[42].TheHMMstrategyadvocates
training community-based service providers to dispense
antimalarials and educate mothers about the correct dose to
give [34]. However surprisingly few programs have consid-
ered using PMS as the community-based service providers.
This might be because of distrust and perceived possibility
of PMS to maximize proﬁt [40]. But Ajayi et al. carried out
a malaria intervention program in Southwest Nigeria using6 Malaria Research and Treatment
Table 2: Appropriateness of doses of antimalarials used by patent medicine sellers in treatment of malaria.
Drug
% PMS who used inappropriate doses % PMS who used
appropriate doses
% Under-dose % Over-dose % Total incorrect % Total correct
Chloroquine 23.2 50.6 73.8 26.3
Sulfadoxine-pyrimethamine 19.2 34.6 53.8 46.2
Halofantrine 40.0 0.0 40.0 60.0
Quinine 100.0 0.0 100.0 0.0
PMS to distribute drugs to mothers, and they reported that
most caregivers perceived PMS as accessible and eﬃcient
at drug distribution [40]. They were quick to add, though
that, for good distribution to be maintained, PMS would
need to receive incentives in the form of commission for
the antimalarials they sold or distributed. Training however
arouses fears that this would be interpreted by the public as
oﬃcial recognition of PMS as health providers. Deﬁnitely
continued supervision is needed to sustain changes and
ensureaminimumstandardofcare.Furtherimprovementin
availability, and quality of public services by the government
is necessary as PMS cannot take the place of public facilities.
However as people are likely to continue to patronize
PMS for a long time, it is recommended that training and
retraining should be made a prerequisite for registering and
reregistering shops. The eﬀect training has on doses and
drugs dispensed in communities needs to be monitored
at regular intervals. Further, more research is needed to
determine what other sorts of interventions involving PMS
could assist in prevention and management of childhood
malaria. The feasibility or otherwise of oﬃcially recognizing
PMS roles in healthcare needs further consideration and
discussion.
5. Conclusion
PMS have the potential to improve malaria control in the
community through improving access of caregivers to eﬀec-
tiveandappropriatetreatment.Interventionsinvolvingthem
should focus on certain key issues—training them on how
to determine the correct dose of appropriate antimalarials,
give advice about drug administration, and use insecticide-
treated nets. They should also be encouraged to use oral
medications instead of injections and ask questions about
illness for which they are consulted. Training, supervision,
and research in various aspects are all needed. Possible
oﬃcial recognition of their roles in healthcare needs further
consideration. If we ignore PMS, we do so at our peril (or
more realisticallyat that of our children).
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